Showing 141 - 160 results of 51,381 for search '(( 5 c decrease ) OR ( 50 ((((ng decrease) OR (nn decrease))) OR (mean decrease)) ))', query time: 0.90s Refine Results
  1. 141
  2. 142

    Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

    Published 2014
    “…Cell stiffness was measured before and after the nanorobotic surgery and decreases from 30.0±1.5 kPa to 20.5±2.8 kPa, respectively. …”
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148

    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

    Published 2019
    “…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
  9. 149

    Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

    Published 2020
    “…(C) A375 melanoma cells were treated with 1.0 μM 5-, 8-, 10-, 12-,14-, or 16-TPP for 1.5 h and analyzed for DHE oxidation (* significant relative to control; p<0.05; n = 3 from 2 separate experiments; N = 6). …”
  10. 150
  11. 151
  12. 152
  13. 153

    ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

    Published 2022
    “…The infections were monitored using live cell imaging for 50 hours. Expression intensities from >50 individual inclusions were measured via automated live-cell fluorescence microscopy and the mean intensities are shown. …”
  14. 154
  15. 155
  16. 156
  17. 157

    Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs. by Yasuzumi Kishimoto (4282138)

    Published 2017
    “…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”
  18. 158
  19. 159
  20. 160